This is not substantive investment research or a research recommendation, as it does not constitute substantive research or analysis. This material should be considered as general market commentary.

 

investment trusts incomeWe look back at our favourite articles of the year – including a somewhat accurate warning in January that Coronavirus might be ‘something to worry about’…

 

The analysts at Kepler Trust Intelligence have produced more than half a million words in the last twelve months. It is fair to assume that a good ten percent of those were anticipating (too early, and for the third year running) a market rotation to value, while at least another ten percent were Callum predicting famine and economic collapse in China, rocketing wheat prices or the demise of Tesla.

As this weary year, the death of which few (except perhaps vendors of PPE) will mourn, draws to a close we look back on some of those words and highlight the articles which, in the opinion of our analysts, stand out most.

Personally, I think the debate between fresh faced young Turk Will ‘Slobbers’ Sobczak and wily old fox William ‘Billy Amory’ Heathcoat Amory back in January must be given credit for its combination of razor-sharp accuracy, blithe confidence and truly, massively, epic understatement.

“Is it time to run away?” was the headline of the piece, which asked whether complacency was in the air, and wondered whether coronavirus might be a ‘potential source of the next market setback’ – a month before the FTSE 100 lost eight years of gains, the pound slid to a 35 year low and a recession on a scale not seen since the Napoleonic wars began.

A direct quote from the article does the rest:

“One can always find something to worry about: the excessive leverage found everywhere in the global financial system, climate change, coronavirus or Middle East tensions (as well as myriad others) are all potential sources of the next market setback or bear phase.”

How very true.

 

William Heathcoat Amory

 

One of the dominant themes for equity markets during 2020 has been the relentless rise of Technology companies. Certainly, COVID-19 has brought forward patterns of behaviour by a factor of years, meaning those companies who have innovative new products have seen a significant improvement in prospects.

This has not gone unnoticed by investors, and so valuations for technology companies have risen.

We believe investors would do well to diversify growth within their portfolio – and specifically to two mega-trends that are set to run for many decades. Both healthcare and climate change are likely to remain huge challenges, but offer companies that address these challenges huge rewards.

The trust universe has plenty of interesting ways of investing in them. We provided an updated and more in depth look at climate change and sustainability in a more recent article which can be found below.

Click here to read the original article in full

Click here to read our more recent update on the same subject

 

 

Thomas McMahon

 

My favourite piece of research this year was Callum’s fascinating investigation into the significance of the growth of passive investing for market behaviour.

With his characteristic combination of analytical rigour and diabolical puns, Calum sketched out some really interesting consequences for investors of the decreasing price-sensitivity of the average dollar spent in the market.

It will be interesting to see whether the wide divergence in performance by country, sector and stock this year leads to some money shifting back into active next year.

However, the technical trend towards passive looks likely to persist in the long run. Most interesting to me in the piece is the point that the growth of passive investing doesn’t actually make it easier to generate alpha.

Click here to read the article in full

 

Callum Stokeld

 

‘Has the time come for Europe?’ we asked in August. In my view this was both topical, but is also likely to remain a useful strategic overview for what the real reason to adjust geographic exposures to go under or overweight Europe is.

It can be easy to look for mean reversion between series which don’t mean revert, but a bullish call on Europe had, and still has, a fundamental macroeconomic call tied into that. This call is nothing to do with endogenous factors.

The outcome since this was published has largely followed expectations: European relative performance to global equities has directionally followed the same pattern as European value relative to European quality (i.e. European value was and remains the conviction beta play on Europe). I expect this to continue to be the case.

That commodities have followed the same general relative direction, but outperformed European equities significantly, further emphasizes the case that Europe is essentially a global macro beta play.

Click here to read the article in full

 

David Johnson

 

ESG has a lot in common with COVID-19 as no matter how much you want to ignore it, it has woven its way into everything we do.

Almost every single investment strategy now makes some form of noise around their ESG credentials, but it can be difficult to see the ESG forest for the trees. How does an investor separate the actual ‘good guys’ from those who are simply box-ticking?

For this reason, my favourite article of 2020 is ‘Nice Guys Finish First’, as it helps to answer this question; “providing a succinct history of ESG and why it matters to investors, as well as, some of the pitfalls and difficulties we face in identifying actual ESG integration. It also gives plenty of examples of potential opportunities for the sustainable-conscious investor.

Click here to read the article in full

 

 

investment forecast

 

Click to visit:

 

investment trusts income

 
Past performance is not a reliable indicator of future results. The value of investments can fall as well as rise and you may get back less than you invested when you decide to sell your investments. It is strongly recommended that Independent financial advice should be taken before entering into any financial transaction.

The information provided on this website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject Kepler Partners LLP to any registration requirement within such jurisdiction or country. In particular, this website is exclusively for non-US Persons. Persons who access this information are required to inform themselves and to comply with any such restrictions.

The information contained in this website is not intended to constitute, and should not be construed as, investment advice. No representation or warranty, express or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. Any views and opinions, whilst given in good faith, are subject to change without notice.

This is not an official confirmation of terms and is not a recommendation, offer or solicitation to buy or sell or take any action in relation to any investment mentioned herein. Any prices or quotations contained herein are indicative only.

Kepler Partners LLP (including its partners, employees and representatives) or a connected person may have positions in or options on the securities detailed in this report, and may buy, sell or offer to purchase or sell such securities from time to time, but will at all times be subject to restrictions imposed by the firm’s internal rules. A copy of the firm’s Conflict of Interest policy is available on request.





Leave a Reply